Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) EBIT : $-2.42 Mil (TTM As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Science Strategic Acquisition Alpha EBIT?

Science Strategic Acquisition Alpha's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2022 was $-0.25 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2022 was $-2.42 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Science Strategic Acquisition Alpha's annualized ROC % for the quarter that ended in Sep. 2022 was -0.25%. Science Strategic Acquisition Alpha's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Science Strategic Acquisition Alpha EBIT Historical Data

The historical data trend for Science Strategic Acquisition Alpha's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Science Strategic Acquisition Alpha EBIT Chart

Science Strategic Acquisition Alpha Annual Data

Trend

Dec20

Dec21

EBIT

-2.95

Science Strategic Acquisition Alpha Quarterly Data
	Oct20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EBIT	Get a 7-Day Free Trial			-0.71	-1.51	-0.32	-0.34	-0.25

Competitive Comparison of Science Strategic Acquisition Alpha's EBIT

For the Shell Companies subindustry, Science Strategic Acquisition Alpha's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Science Strategic Acquisition Alpha's EV-to-EBIT Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Science Strategic Acquisition Alpha's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Science Strategic Acquisition Alpha's EV-to-EBIT falls into.

Science Strategic Acquisition Alpha EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.42 Mil.

Science Strategic Acquisition Alpha (NAS:SSAAU) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Science Strategic Acquisition Alpha's annualized ROC % for the quarter that ended in Sep. 2022 is calculated as:

	ROC % (Q: Sep. 2022 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2022 )	+	Invested Capital (Q: Sep. 2022 ))	/ count )
=	-0.996 * ( 1 - 21.32% )	/	( (311.53	+	312.573)	/ 2 )
=	-0.7836528	/	312.0515
=	-0.25 %

where

	Invested Capital		(Q: Jun. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	311.531	-	1.584	-	( 0.512	-	max(0, 2.334	-	0.751	+	0.512	))
=	311.53

	Invested Capital		(Q: Sep. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	312.401	-	1.964	-	( 0.445	-	max(0, 2.714	-	0.578	+	0.445	))
=	312.573

Note: The Operating Income data used here is four times the quarterly (Sep. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

Science Strategic Acquisition Alpha's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2022 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2022		Q: Sep. 2022
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.996	/	( ( (0 + max(-1.345, 0))	+	(0 + max(-1.831, 0)) )	/	2 )
=	-0.996	/	( ( 0	+	0 )	/	2 )
=	-0.996	/	0
=	%

where Working Capital is:

	Working Capital		(Q: Jun. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.239)	-	(1.584	+	0	+	0)
=	-1.345

	Working Capital		(Q: Sep. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.133)	-	(1.964	+	0	+	0)
=	-1.831

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Science Strategic Acquisition Alpha's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2022 )
	=	-2.42	/	0.000
	=	%

Science Strategic Acquisition Alpha EBIT Related Terms

Thank you for viewing the detailed overview of Science Strategic Acquisition Alpha's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Science Strategic Acquisition Corp Alpha (NAS:SSAAU) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

1447 2nd Street, Suite 200, Santa Monica, CA, USA, 90401

Website

https://www.science-inc.com

Science Strategic Acquisition Corp Alpha is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Executives

Michael Gwynne Jones	director, officer: CEO	24460 MALIBU ROAD, MALIBU CA 90265
Jeff Kearl	director	C/O SKULLCANDY, INC., 1441 WEST UTE BLVD., SUITE 250, PARK CITY UT 84908
April Henry	officer: EVP, Corporate Development	C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Jennifer Rubio	director	C/O TISHMAN SPEYER PROPERTIES, L.P., ROCKEFELLER CENTER, 45 ROCKEFELLER PLAZA, NEW YORK NY 10111
Taylor Colette K.	director	C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Greg Gilman	director	C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Priscilla Guevara	officer: Global Head of IR	C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Tom Dare	officer: CFO	C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Peter Pham	officer: President	C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401

Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Headlines

No Headlines